Figure 3
MDM2 immunostaining performed on the core needle biopsy from the liposarcoma depicted in Figure 1 showing rare tumor cell positivity (1+) ( × 10).
Figure 3 | Modern Pathology
MDM2 immunostaining performed on the core needle biopsy from the liposarcoma depicted in Figure 1 showing rare tumor cell positivity (1+) ( × 10).
